Cargando…

Evaluation of Cell-Penetrating Peptides as Mucosal Immune Enhancers for Nasal Vaccination

Cell-penetrating peptides (CPPs) have been evaluated as enhancers in drug delivery, their addition in medical formulations favors drug absorption allowing obtaining the pharmacological effect with lower doses. In vaccine formulations their inclusion has been also explored with interesting results. C...

Descripción completa

Detalles Bibliográficos
Autores principales:	Lobaina, Yadira, Urquiza, Dioslaida, Garay, Hilda, Perera, Yasser, Yang, Ke
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Springer Netherlands 2021
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8511864/ https://www.ncbi.nlm.nih.gov/pubmed/34658688 http://dx.doi.org/10.1007/s10989-021-10296-8

Ejemplares similares

Protective cellular immune response against hepatitis C virus elicited by chimeric protein formulations in BALB/c mice
por: Olivera, Santa, et al.
Publicado: (2020)

Five-year Follow-up of Chronic Hepatitis B Patients Immunized by Nasal Route with the Therapeutic Vaccine HeberNasvac
por: Fernández, Guillermo, et al.
Publicado: (2018)

Chrysanthemum sporopollenin: A novel vaccine delivery system for nasal mucosal immunity
por: Liu, Jun, et al.
Publicado: (2023)

Editorial: Mucosal Vaccination: Strategies to Induce and Evaluate Mucosal Immunity
por: Kozlowski, Pamela A., et al.
Publicado: (2022)

Riboflavin as a Mucosal Adjuvant for Nasal Influenza Vaccine
por: Yin, Yinyan, et al.
Publicado: (2021)

Systemic and brain delivery of antidiabetic peptides through nasal administration using cell-penetrating peptides
por: Maeng, Jeehye, et al.
Publicado: (2022)

Endocine™, N3OA and N3OASq; Three Mucosal Adjuvants That Enhance the Immune Response to Nasal Influenza Vaccination
por: Falkeborn, Tina, et al.
Publicado: (2013)

Nasal delivery of Protollin-adjuvanted H5N1 vaccine induces enhanced systemic as well as mucosal immunity in mice
por: Cao, Weiping, et al.
Publicado: (2017)

Mucus-penetrating nonviral gene vaccine processed in the epithelium for inducing advanced vaginal mucosal immune responses
por: Bi, Qunjie, et al.
Publicado: (2023)

Cell-penetrating peptides enhance peptide vaccine accumulation and persistence in lymph nodes to drive immunogenicity
por: Backlund, Coralie M., et al.
Publicado: (2022)

Importance of nasal secretions in the evaluation of mucosal immunity elicited by mRNA BNT162b2 COVID-19 Vaccine
por: Francavilla, Beatrice, et al.
Publicado: (2022)

Association between Microbiota and Nasal Mucosal Diseases in terms of Immunity
por: Tai, Junhu, et al.
Publicado: (2021)

The Role of Combined Penetration Enhancers in Nasal Microspheres on In Vivo Drug Bioavailability
por: Rassu, Giovanna, et al.
Publicado: (2018)

Mucosal Vaccination for Influenza Protection Enhanced by Catalytic Immune‐Adjuvant
por: Qin, Tao, et al.
Publicado: (2020)

Suppression of mucosal Th17 memory responses by acellular pertussis vaccines enhances nasal Bordetella pertussis carriage
por: Dubois, Violaine, et al.
Publicado: (2021)

The construction of in vitro nasal cavity-mimic M-cell model, design of M cell-targeting nanoparticles and evaluation of mucosal vaccination by nasal administration
por: Yang, Xiaotong, et al.
Publicado: (2020)

Cell-Penetrating Peptides: Efficient Vectors for Vaccine Delivery
por: Yang, Jieru, et al.
Publicado: (2019)

Conjugation of Cell-Penetrating Peptides to Antimicrobial Peptides Enhances Antibacterial Activity
por: Lee, Hyunhee, et al.
Publicado: (2019)

Formyl peptide receptors in the mucosal immune system
por: Jeong, Yu Sun, et al.
Publicado: (2020)

The Respiratory Commensal Bacterium Corynebacterium pseudodiphtheriticum as a Mucosal Adjuvant for Nasal Vaccines
por: Ortiz Moyano, Ramiro, et al.
Publicado: (2023)

Toxicity evaluation and nasal mucosal tissue deposition of dexamethasone-infused mucoadhesive in situ nasal gelling systems
por: Pandey, Preeti, et al.
Publicado: (2019)

Immunotherapy for Chronic Hepatitis B using HBsAg-based Vaccine Formulations: From Preventive Commercial Vaccines to Therapeutic Approach Julio Cesar Aguilar,
por: Cesar Aguilar, Julio, et al.
Publicado: (2014)

Objective evaluation of the nasal mucosal secretion in COVID-19 patients with anosmia
por: Islamoglu, Yuce, et al.
Publicado: (2020)

Nasal Lipopolysaccharide Challenge and Cytokine Measurement Reflects Innate Mucosal Immune Responsiveness
por: Dhariwal, Jaideep, et al.
Publicado: (2015)

Use of Cell-Penetrating Peptides in Dendritic Cell-Based Vaccination
por: Lim, Sangho, et al.
Publicado: (2016)

Cell-penetrating peptides—the Swiss Army knife of cancer vaccines
por: Walker, Paul R., et al.
Publicado: (2015)

Cell-Penetrating Peptides-Based Liposomal Delivery System Enhanced Immunogenicity of Peptide-Based Vaccine against Group A Streptococcus
por: Yang, Jieru, et al.
Publicado: (2021)

Alpha-galactosylceramide enhances mucosal immunity to oral whole-cell cholera vaccines
por: Davitt, Christopher J. H., et al.
Publicado: (2019)

Tumor-Penetrating Peptides
por: Teesalu, Tambet, et al.
Publicado: (2013)

The Upper Nasal Space: Option for Systemic Drug Delivery, Mucosal Vaccines and “Nose-to-Brain”
por: Shrewsbury, Stephen B.
Publicado: (2023)

Systemic and mucosal humoral immune responses induced by the JY-adjuvanted nasal spray H7N9 vaccine in mice
por: Xu, Jing, et al.
Publicado: (2018)

A nasal vaccine with inactivated whole-virion elicits protective mucosal immunity against SARS-CoV-2 in mice
por: Tokunoh, Nagisa, et al.
Publicado: (2023)

Enhanced Nasal Mucosal Delivery and Immunogenicity of Anti-Caries DNA Vaccine through Incorporation of Anionic Liposomes in Chitosan/DNA Complexes
por: Chen, Liulin, et al.
Publicado: (2013)

Enhanced cellular uptake of lactosomes using cell-penetrating peptides
por: Akahoshi, Akiya, et al.
Publicado: (2016)

Cell-Penetrating Peptides to Enhance Delivery of Oligonucleotide-Based Therapeutics
por: McClorey, Graham, et al.
Publicado: (2018)

Hydroxyethylcellulose-Based Hydrogels Containing Liposomes Functionalized with Cell-Penetrating Peptides for Nasal Delivery of Insulin in the Treatment of Diabetes
por: Von Zuben, Eliete de Souza, et al.
Publicado: (2022)

Innate and adaptive nasal mucosal immune responses following experimental human pneumococcal colonization
por: Jochems, Simon P., et al.
Publicado: (2019)

Age-related Differences in the Nasal Mucosal Immune Response to SARS-CoV-2
por: Koch, Clarissa M., et al.
Publicado: (2021)

Innate and adaptive nasal mucosal immune responses following experimental human pneumococcal colonization
por: Jochems, Simon P., et al.
Publicado: (2022)

Mucosal and cellular immune responses elicited by nasal and intramuscular inoculation with ASFV candidate immunogens
por: Xu, Lulu, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_7impmpmraba64mpt4ectao53ed